India Price Regulator Urged To Cut New Price Approvals To 30 Days
This article was originally published in PharmAsia News
Executive SummaryIndia's National Pharmaceutical Pricing Authority is being pressured by other parts of the government to cut in half the clearance time for pricing changes, which now take 60 days. The Department of Chemicals and Petrochemicals requested reduction of the approval period to 30 days to satisfy industry complaints about the recent increase in prices of bulk drugs from China. Many Indian drug makers have been applying for permission to raise prices, including those who make bulk drugs. Some industry groups urge a 20 percent increase in the consumer drugs, bulks by 25 percent. (Click here for more
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.